Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
DCC Blocking Peptide (AC1294)
Cat.#: ACPP-1294
Specifications
Despition DCC Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1044 Recombinant Human RAGE Protein (6×His Tag) (AC1044) 50 µg inquiry ACPP-1592 Human CRYAB Protein (AC1592) 20 µg inquiry ACPP-1808 Human LIF Protein, Yeast (AC1808) 5 µg inquiry ACPP-1368 KCNJ2 Blocking Peptide (AC1368) 250 µg inquiry ACPP-1753 Human SPR Protein (AC1753) 5 µg inquiry ACPP-1282 Human SIAH1 Protein (AC1282) 2 µg inquiry ACPP-1064 Recombinant Human LSAMP Protein (Fc Tag) (AC1064) 50 µg inquiry ACPP-1516 Human Insulin Protein, Yeast (AC1516) 2 mg inquiry ACPP-1414 Human BEX1 Protein (AC1414) 2 µg inquiry ACPP-1534 Human RLN3 Protein (AC1534) 5 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket